These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 19631619)

  • 1. Polarized P-glycoprotein expression by the immortalised human brain endothelial cell line, hCMEC/D3, restricts apical-to-basolateral permeability to rhodamine 123.
    Tai LM; Reddy PS; Lopez-Ramirez MA; Davies HA; Male DK; Loughlin AJ; Romero IA
    Brain Res; 2009 Oct; 1292():14-24. PubMed ID: 19631619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-brain barrier cell line PBMEC/C1-2 possesses functionally active P-glycoprotein.
    Neuhaus W; Stessl M; Strizsik E; Bennani-Baiti B; Wirth M; Toegel S; Modha M; Winkler J; Gabor F; Viernstein H; Noe CR
    Neurosci Lett; 2010 Jan; 469(2):224-8. PubMed ID: 19963040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies.
    Cucullo L; Couraud PO; Weksler B; Romero IA; Hossain M; Rapp E; Janigro D
    J Cereb Blood Flow Metab; 2008 Feb; 28(2):312-28. PubMed ID: 17609686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system.
    Feng B; Mills JB; Davidson RE; Mireles RJ; Janiszewski JS; Troutman MD; de Morais SM
    Drug Metab Dispos; 2008 Feb; 36(2):268-75. PubMed ID: 17962372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine signaling in the human brain capillary endothelial cell line hCMEC/D3.
    Fasler-Kan E; Suenderhauf C; Barteneva N; Poller B; Gygax D; Huwyler J
    Brain Res; 2010 Oct; 1354():15-22. PubMed ID: 20692239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
    Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
    Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay.
    Döppenschmitt S; Langguth P; Regårdh CG; Andersson TB; Hilgendorf C; Spahn-Langguth H
    J Pharmacol Exp Ther; 1999 Jan; 288(1):348-57. PubMed ID: 9862789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of blood-brain barrier properties in cultured brain capillary endothelial cells: comparison between primary glial cells and C6 cell line.
    Boveri M; Berezowski V; Price A; Slupek S; Lenfant AM; Benaud C; Hartung T; Cecchelli R; Prieto P; Dehouck MP
    Glia; 2005 Aug; 51(3):187-98. PubMed ID: 15800928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of imatinib mesilate with human P-glycoprotein.
    Hamada A; Miyano H; Watanabe H; Saito H
    J Pharmacol Exp Ther; 2003 Nov; 307(2):824-8. PubMed ID: 12975485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and functional activity of P-glycoprotein in passaged primary human nasal epithelial cell monolayers cultured by the air-liquid interface method for nasal drug transport study.
    Cho HJ; Choi MK; Lin H; Kim JS; Chung SJ; Shim CK; Kim DD
    J Pharm Pharmacol; 2011 Mar; 63(3):385-91. PubMed ID: 21749386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein-mediated efflux of phenobarbital at the blood-brain barrier evidence from transport experiments in vitro.
    Yang ZH; Liu XD
    Epilepsy Res; 2008 Jan; 78(1):40-9. PubMed ID: 18063342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters.
    Perrière N; Yousif S; Cazaubon S; Chaverot N; Bourasset F; Cisternino S; Declèves X; Hori S; Terasaki T; Deli M; Scherrmann JM; Temsamani J; Roux F; Couraud PO
    Brain Res; 2007 May; 1150():1-13. PubMed ID: 17434463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line.
    Zastre JA; Chan GN; Ronaldson PT; Ramaswamy M; Couraud PO; Romero IA; Weksler B; Bendayan M; Bendayan R
    J Neurosci Res; 2009 Mar; 87(4):1023-36. PubMed ID: 18855943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
    Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
    J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of drug efflux transport kinetics in various blood-brain barrier models.
    Bachmeier CJ; Trickler WJ; Miller DW
    Drug Metab Dispos; 2006 Jun; 34(6):998-1003. PubMed ID: 16554372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier.
    He L; Zhao C; Yan M; Zhang LY; Xia YZ
    Phytother Res; 2009 Jul; 23(7):933-7. PubMed ID: 19172664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional expression and localization of P-glycoprotein at the blood brain barrier.
    Bendayan R; Lee G; Bendayan M
    Microsc Res Tech; 2002 Jun; 57(5):365-80. PubMed ID: 12112443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.
    Ohtsuki S; Ikeda C; Uchida Y; Sakamoto Y; Miller F; Glacial F; Decleves X; Scherrmann JM; Couraud PO; Kubo Y; Tachikawa M; Terasaki T
    Mol Pharm; 2013 Jan; 10(1):289-96. PubMed ID: 23137377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro-to-in vivo prediction of P-glycoprotein-based drug interactions at the human and rodent blood-brain barrier.
    Hsiao P; Bui T; Ho RJ; Unadkat JD
    Drug Metab Dispos; 2008 Mar; 36(3):481-4. PubMed ID: 18057117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro models for the blood-brain barrier.
    Garberg P; Ball M; Borg N; Cecchelli R; Fenart L; Hurst RD; Lindmark T; Mabondzo A; Nilsson JE; Raub TJ; Stanimirovic D; Terasaki T; Oberg JO; Osterberg T
    Toxicol In Vitro; 2005 Apr; 19(3):299-334. PubMed ID: 15713540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.